Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection rep-resent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summa-rized the investigational therapies in the pipeline. Furthermore, we discussed some critical issues such as a “functional cure” approach, the futility of long-term NA therapy and the relevance of understanding drug actions and safety of antivirals, especially in special populations.
HBV and HDV: New Treatments on the Horizon
Zuccaro, Valentina
;Asperges, Erika;Marvulli, Lea Nadia;Bruno, Raffaele
2021-01-01
Abstract
Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection rep-resent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summa-rized the investigational therapies in the pipeline. Furthermore, we discussed some critical issues such as a “functional cure” approach, the futility of long-term NA therapy and the relevance of understanding drug actions and safety of antivirals, especially in special populations.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
